AI-generated summary
This randomized, single-blind trial of 36 head and neck cancer patients with grade 3-4 oral mucositis compared diode laser photobiomodulation (810 nm) with a mouthwash. The authors report that laser therapy reduced pain, improved quality of life and lowered mucositis severity within the first week, but the severity difference was not significant at one month.
- Participants
- 36
- Who or what was studied
- Head and neck cancer patients with grade 3-4 oral mucositis induced by chemoradiotherapy
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract reports a small sample of 36 patients split into two groups of 18, and the mucositis severity benefit was not significant at one month.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Energy density (fluence)
- 6 J/cm2
- Power
- 200 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation, Oral mucositis, Low-level laser therapy, Control group, Wavelength, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.